Literature DB >> 8769280

Enzymatic determination of serum 3 alpha-sulfated bile acids concentration with bile acid 3 alpha-sulfate sulfohydrolase.

T Kato1, M Yoneda, K Nakamura, I Makino.   

Abstract

A newly developed enzymatic method for determining urinary 3 alpha-sulfated bile acids was used to measure serum 3 alpha-sulfated bile acid levels in 114 patients with hepatobiliary diseases and 56 healthy subjects. The lowest measurable amount of the 3 alpha-sulfated bile acids was 0.5 mumol/liter. The standard curves for glycolithocholic acid 3 alpha-sulfate, glycoursodeoxycholic acid 3 alpha-sulfate, and lithocholic acid 3 alpha-sulfate were linear from 0.5 to 250 mumol/liter. Specificity of the assay was satisfactory and intra- and interassay variations ranged from 0.8 to 4.4% and from 1.2 to 7.9%, respectively. Analytical recovery was more than 91%. The values obtained by this assay were well correlated with those by gas-liquid chromatography measurement (r = 0.91, P < 0.01). The fasting serum 3 alpha-sulfated bile acids level in healthy subjects ranged from undetectable to 1.9 mumol/liter (mean +/- SE; 0.9 +/- 0.1 mumol/liter). The percentage of 3 alpha-sulfated bile acids in total bile acids (sum of 3 alpha-sulfated and 3 alpha-hydroxy bile acids) in serum was 16.8 +/- 1.5%. In subjects with hepatobiliary diseases, serum 3 alpha-sulfated bile acids levels were elevated; however, the percentage of 3 alpha-sulfated bile acids in total bile acids was decreased and correlated with the severity of hepatocellular insufficiency. This enzymatic assay is simple, rapid, and accurate for the determination of serum 3 alpha-sulfated bile acids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769280     DOI: 10.1007/bf02087901

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Bile acid profiles in urine of patients with liver diseases.

Authors:  A Bremmelgaard; J Sjövall
Journal:  Eur J Clin Invest       Date:  1979-10       Impact factor: 4.686

2.  A simple and sensitive assay of total serum bile acids.

Authors:  F Mashige; K Imai; T Osuga
Journal:  Clin Chim Acta       Date:  1976-07-01       Impact factor: 3.786

3.  Synthesis of bile acid monosulphates by the isolated perfused rat kidney.

Authors:  J A Summerfield; J L Gollan; B H Billing
Journal:  Biochem J       Date:  1976-05-15       Impact factor: 3.857

4.  Enzymatic sulphation of bile salts in human liver.

Authors:  L Lööf; B Wengle
Journal:  Biochim Biophys Acta       Date:  1978-09-28

5.  The enzymatic cleavage of the carbon-nitrogen bond in 3-alpha, 7-alpha, 12-alpha-trihydroxy-5-beta-cholan-24-oylglycine.

Authors:  P P Nair; M Gordon; J Reback
Journal:  J Biol Chem       Date:  1967-01-10       Impact factor: 5.157

6.  Sulfation and renal excretion of bile salts in patients with cirrhosis of the liver.

Authors:  A Stiehl; D L Earnest; W H Admirant
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

7.  Evidence for renal control of urinary excretion of bile acids and bile acid sulphates in the cholestatic syndrome.

Authors:  J A Summerfield; J Cullen; S Barnes; B H Billing
Journal:  Clin Sci Mol Med       Date:  1977-01

8.  Analysis of 3-sulfated and nonsulfated bile acids by one-step solvolysis and high performance liquid chromatography.

Authors:  Y Hirano; H Miyazaki; S Higashidate; F Nakayama
Journal:  J Lipid Res       Date:  1987-12       Impact factor: 5.922

9.  Glucuronidated and sulfated bile acids in serum of patients with acute hepatitis.

Authors:  H Takikawa; T Beppu; Y Seyama; T Sugimoto
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

10.  Diurnal changes in serum unconjugated bile acids in normal man.

Authors:  K D Setchell; A M Lawson; E J Blackstock; G M Murphy
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

View more
  1 in total

Review 1.  Activation of muscarinic receptor signaling by bile acids: physiological and medical implications.

Authors:  Jean-Pierre Raufman; Kunrong Cheng; Piotr Zimniak
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.